《大行報告》瑞銀上調普拉達(01913.HK)目標價至64元 評級「買入」
瑞銀發表研究報告,指普拉達(01913.HK)上半年業績續轉勢,收入增長加快,另7月零售表現較2019年同期水平錄約13%至17%增長,而上半年增長為8%。
該行指出,在不同地域、產品類別,增長都呈健康態勢,品牌被認為「潮」。普拉達上半年EBIT利潤率為11.1%,高於該行及市場預期的7.7%及9.2%,主因門店生產力改善,以及上半年推廣開支較2019年同期增長25%。該行表示,樂見推廣開支增加,而增加的開支可被經營槓桿所抵銷,升2021至2023年每股盈測分別4%、4%及1%,重申「買入」評級,目標價由62元升至64元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.